Dr. Michael Kaplan Responds to CBS Prostate Study, Says New Findings Could Help Men Everywhere

Share Article

The latest medical findings show that dutasteride, a drug commonly used to treat enlarged prostates, might also be effective in curbing the growth of prostate cancer, something that urologist Dr. Michael Kaplan says could have a huge impact on prostate treatment.

A drug called dutasteride has long been used to treat enlarged prostates, but new evidence suggests that it might also promote prostate health in other ways. According to a new study from CBS, the drug has been shown as effective in delaying the growth of prostate cancer. These findings could potentially be revelatory to the way doctors treat prostate cancer. Unsurprisingly, the study has won the attention of several prominent urologists, including Las Vegas physician Dr. Michael Kaplan.

Dr. Michael Kaplan says the study could have major ramifications for the way prostate treatment is approached. To be sure, the CBS report indicated a great degree of potency and efficacy with this drug. The findings show that the growth of prostate cancer in men who took the drug was only 38%, while men who took the placebo experienced cancerous growth of 48%.

“In addition to potentially reducing the incidence of low-grade prostate cancer, this drug reduces the probability of ever requiring prostate surgery by 50 percent,” comments Dr. Michael Kaplan. “It also reduces prostate volume consistently by 30 percent.” The Las Vegas urologist then offers his personal endorsement, saying that he takes the medication himself.

A study of this caliber has attracted attention and support from urologists beyond Dr. Michael Kaplan, as well. The CBS report quotes another prominent doctor who believes the study’s implications are “profound.” Additionally, the study’s author is quoted in saying that the drug “provides a treatment option for men with low-risk, localized disease,” though whether the study will ultimately affect the mortality rate associated with prostate cancer remains to be seen.

The National Cancer Institute, meanwhile, projects that some 242,000 men will be diagnosed with prostate cancer this year. According to doctors like Dr. Michael Kaplan, however, studies like this one are going a long way toward providing new models for minimizing the risk of prostate cancer, and offering new avenues for potential treatment.

Dr. Michael Kaplan is a urologist whose practice is located in Las Vegas, Nevada. A physician who specializes in performing vasectomies, Dr. Michael Kaplan provides a number of services to patients, including those pertaining to prostate health, erectile dysfunction, pelvic organ prolapse, urinary incontinence, and Peyronie's Disease.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Micheal McGarety
PR Authority
Email >